|
|
|
|
|
|
|
Join Thermo Fisher Scientific at ECCMID 2024, 27-30 April in Barcelona, Booth C9
|
|
|
|
|
| |
Let us help empower your expertise at ECCMID 2024 with innovative solutions to fight antimicrobial resistance (AMR), perform molecular testing for infectious disease pathogens, and guide effective outcomes.
Stop by Booth C9 to see our latest solutions for antimicrobial susceptibility testing (AST) and molecular diagnostic testing for microbial and viral pathogen detection. Plus:
|
|
|
| |
Register for our Innovation & Pipeline Theater events:
- Critical results for critical samples
Federico Pea, MD, FISAC Full Professor of Pharmacology, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Italy;
Head SSD Clinical Pharmacology - Dept. Integrated Management of Infectious Risk University Hospital IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy
- Development and implementation of a customised rapid syndromic test for severe pneumonia
Dr Andrew Conway Morris, MBChB(hons), BSc(hons), PhD, MRCP, FRCA, FFICM, MRC Clinician Scientist, University of Cambridge, Hon Consultant in Intensive Care Medicine, Addenbrookes Hospital, Cambridge, Mackintosh Professor, Royal College of Anaesthetists
- New solutions for nucleic acid detection using 1-step RT-qPCR
Agnė Žiupkaitė, Product Manager, Custom Commercial Supply, Thermo Fisher Scientific
And, visit our scientific posters:
- Clinical performance evaluation of a real-time PCR-based test for the detection of high-risk HPV genotypes
- Comparison of AI-assisted and manual interpretation of disc diffusion test from 12 antibiotics of Pseudomonas aeruginosa
- Enhancing pathogen detection in viral respiratory tract infections among individuals aged>55 years through expanded PCR panel testing
- Performance evaluation of an expanded PCR panel for uropathogen identification in urinary tract infections compared to standard urine culture
- Evaluation of the equivalency of the Oxoid aztreonam/avibactam (30/20 μg) antimicrobial susceptibility testing disc to the CLSI M07 broth microdilution frozen reference method
- Evaluation of the Oxoid imipenem/relebactam (10/25 µg) antimicrobial susceptibility testing (AST) disc against the predicate AST disc
See the schedule of events and what’s in the booth »
|
| |
|
|
| |
